![James McNulty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James McNulty
Director of Finance/CFO at
HEDGEPATH PHARMACEUTICALS INC
Net worth: 152 786 $ as of 31/07/2026
Profile
James A. McNulty is the founder of Pender, McNulty & Newkirk, founded in 1976.
Mr. McNulty is also the founder of McNulty & Co.,McNulty, Garcia & Ortiz PA..
Mr. McNulty is Director-Tampa Bay Chapter at Financial Executives International since 2013.
Mr. McNulty is Independent Director at Lunai Bioworks, Inc. starting 2024.
Mr. McNulty is a Member of The American Institute of Certified Public Accountants.
Mr. McNulty is a Member of Florida Institute of Certified Public Accountants.
Mr. McNulty is Chief Financial Officer, Secretary & Treasurer at Inhibitor Therapeutics, Inc. since 2022.
Mr. McNulty is Chief Financial Officer at Repurposed Therapeutics, Inc. Mr. McNulty is Chief Financial Officer at MIRALOGX LLC.
Former positions include Chief Executive Officer at MyMD Pharmaceuticals (Florida), Inc. from 2014 to 2020.
Lead Independent Director at CV Sciences, Inc. from 2016 to 2020.
Director at Quantum Technology Sciences, Inc. Chief Financial Officer at Rock Creek Pharmaceuticals, Inc. from 1998 to 2000.
Treasurer & Senior Vice President at BioDelivery Sciences International, Inc. from 2013 to 2014.
Chief Financial Officer at CeleXx Corp.
Chief Financial Officer at BioVest International, Inc. from 2003 to 2007.
Secretary & Treasurer at Accentia Biopharmaceuticals, Inc. from 2009 to 2013.
Chief Operating & Financial Officer at American Prescription Providers, Inc. from 2000 to 2002.
Chief Financial Officer at TEAMM Pharmaceuticals, Inc. Chief Financial Officer at RetinaPharma Technologies, Inc. Chief Financial Officer at Hopkins Capital Group.
Chief Financial Officer at Telomir Pharmaceuticals, Inc. Chief Executive & Financial Officer at Defender Pharmaceuticals, Inc. Chief Financial Officer at MIRA Pharmaceuticals, Inc. from 2020 to 2023.
Education includes undergraduate degree from the University of South Florida, conferred in 1972.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/08/2026 | 19,46,135 ( 1.13% ) | 149 852 $ | 31/07/2026 | |
LUNAI BIOWORKS, INC. 0.03% | 10/04/2026 | 1,512 ( 0.03% ) | 2 933 $ | 31/07/2026 |
James McNulty active positions
| Companies | Position | Start |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Director of Finance/CFO | 13/12/2022 |
| LUNAI BIOWORKS INC. | Director/Board Member | 14/10/2024 |
Repurposed Therapeutics, Inc. | Director of Finance/CFO | - |
Financial Executives International
 Financial Executives International Miscellaneous Commercial ServicesCommercial Services Operates as a association for treasurers, controllers, tax executives and financial services | Corporate Officer/Principal | - |
Florida Institute of Certified Public Accountants
 Florida Institute of Certified Public Accountants The Florida Institute of Certified Public Accountants (FICPA) is a professional organization representing certified public accountants and accounting professionals in public accounting, private industry, government, and education. The private company is based in Tallahassee, FL. FICPA provides services such as continuing professional education, career development programs, leadership opportunities, advocacy, and resources for all career stages. The organization offers educational resources including conferences, online courses, and specialized programs on industry topics, and administers the mandatory AICPA peer review program to ensure quality control in accounting and auditing firms. FICPA also runs initiatives like the corporate membership program and the "Bridge to CPA" pilot program, which offers tuition-free, fully online pathways for future CPAs. Advocacy efforts include monitoring legislation, organizing events, and publishing updates on tax and regulatory matters. The organization promotes volunteerism and maintains 22 local chapters statewide for networking, education, philanthropy, and leadership development. Members have access to career resources such as job postings, scholarships, exam preparation discounts, and a members-only portal. Deborah Curry has been the CEO of the company since 2011. | Corporate Officer/Principal | - |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Former positions of James McNulty
| Companies | Position | End |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/01/2024 |
| MIRA PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/04/2023 |
| CV SCIENCES, INC. | Director/Board Member | 27/07/2020 |
| ░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of James McNulty
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
25
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 25 |
|---|---|
Rock Creek Pharmaceuticals, Inc.
 Rock Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures a variety of pharmaceutical products | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
CeleXx Corp.
 CeleXx Corp. Information Technology ServicesTechnology Services Provides hardware and software integration & learning management integration | Technology Services |
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Health Technology |
Accentia Biopharmaceuticals, Inc.
 Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceuticals | Health Technology |
CV Sciences, Inc.
 CV Sciences, Inc. Pharmaceuticals: OtherHealth Technology Manufactures, markets and sells products containing hemp oil | Health Technology |
Lunai Bioworks, Inc.
 Lunai Bioworks, Inc. BiotechnologyHealth Technology Operates as preclinical stage biotechnology company developing technologies and therapies for HIV, HBV and cancer | Health Technology |
American Prescription Providers, Inc.
 American Prescription Providers, Inc. Drugstore ChainsRetail Trade Retails pharmaceutical products | Retail Trade |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
TEAMM Pharmaceuticals, Inc.
 TEAMM Pharmaceuticals, Inc. Medical DistributorsDistribution Services Markets and sells prescription pharmaceutical products | Distribution Services |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Financial Executives International
Financial Executives International Miscellaneous Commercial ServicesCommercial Services Operates as a association for treasurers, controllers, tax executives and financial services | Commercial Services |
Florida Institute of Certified Public Accountants
Florida Institute of Certified Public Accountants The Florida Institute of Certified Public Accountants (FICPA) is a professional organization representing certified public accountants and accounting professionals in public accounting, private industry, government, and education. The private company is based in Tallahassee, FL. FICPA provides services such as continuing professional education, career development programs, leadership opportunities, advocacy, and resources for all career stages. The organization offers educational resources including conferences, online courses, and specialized programs on industry topics, and administers the mandatory AICPA peer review program to ensure quality control in accounting and auditing firms. FICPA also runs initiatives like the corporate membership program and the "Bridge to CPA" pilot program, which offers tuition-free, fully online pathways for future CPAs. Advocacy efforts include monitoring legislation, organizing events, and publishing updates on tax and regulatory matters. The organization promotes volunteerism and maintains 22 local chapters statewide for networking, education, philanthropy, and leadership development. Members have access to career resources such as job postings, scholarships, exam preparation discounts, and a members-only portal. Deborah Curry has been the CEO of the company since 2011. | |
RetinaPharma Technologies, Inc.
 RetinaPharma Technologies, Inc. Medical DistributorsDistribution Services Develops products for the prevention, treatment, and diagnosis | Distribution Services |
Pender, McNulty & Newkirk | |
McNulty & Co.
 McNulty & Co. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
McNulty, Garcia & Ortiz PA | |
Quantum Technology Sciences, Inc.
 Quantum Technology Sciences, Inc. Aerospace & DefenseElectronic Technology Designs tactical geophysical technology | Electronic Technology |
Hopkins Capital Group
 Hopkins Capital Group Investment ManagersFinance Hopkins Capital invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for buyout transactions. | Finance |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Repurposed Therapeutics, Inc. | |
MyMD Pharmaceuticals (Florida), Inc.
 MyMD Pharmaceuticals (Florida), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops therapeutic platforms | Health Technology |
Defender Pharmaceuticals, Inc.
 Defender Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of pharmaceuticals | Health Technology |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
- Stock Market
- Insiders
- James McNulty
